Arpan Mohanty, MBBS
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Gastroenterology

MBBS, Rajiv Gandhi University of Health Sciences



Arpan Mohanty, MD, MSc is a hepatologist and clinical researcher at Boston Medical Center and Assistant Professor of Medicine Boston University Chobanian & Avedisian School of Medicine. Dr. Mohanty serves as the Director of Clinical Research in the Section of Gastroenterology
Dr. Mohanty’s research focuses on optimizing health-care delivery for advanced chronic liver disease and fatty liver disease. Her work has been supported by the National Institute on Minority Health and Health Disparities, the American Association for the Study of Liver Diseases, and the Radiological Society of North America, and she is the current recipient of the Robert Winn Career Development Award that focuses on community-oriented clinical trialists. She also serves as the principal investigator for several trials on chronic liver diseases. She is an active member of the American Association of Study of Liver Diseases and serves in its practice guidelines committee and fundamentals of liver disease committee.
Dr. Mohanty earned her medical degree in India, completed her internal medicine residency at the University of Pittsburgh Medical Center, gastroenterology fellowship at Yale New Haven Hospital, and advanced hepatology fellowship at Massachusetts General Hospital. She also holds a Master’s in Population Health from the Boston University School of Public Health. She is board certified in Internal Medicine, Gastroenterology, Transplant Hepatology and Obesity Medicine.



TAK-999-3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency–Associated Liver Disease With METAVIR Stage F2 to F4 Fibrosis
03/26/2024 - 03/26/2029 (PI)
Takeda Pharmaceuticals


K-001-201: A PHASE 2, MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND, 48-WEEK STUDY TO EVALUATE THE EFFICACY AND SAFETY OF COMBINATION THERAPY OF K-877-ER AND CSG452 IN PATIENTS WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH) WITH L
08/08/2024 - 08/08/2027 (PI)
Kowa Research Institute, Inc.


Global Longitudinal Assessment of Nonalcoholic Fatty Liver Disease (NAFLD) using Magnetic Resonance Elastography GOLD-MINE Study Protocol
06/15/2020 - 08/03/2027 (Multi-PI)
PI: Arpan Mohanty, MBBS
The Regents of the University of Calif., U.C. San Diego Astrazeneca Pharm


NN9500-7730: Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease
05/29/2024 - 05/29/2027 (PI)
Novo Nordisk


MGL-3196-19: A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)
01/24/2024 - 01/24/2027 (PI)
Madrigal Pharmaceuticals, Inc.


Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA)
10/16/2024 - 01/15/2027 (Subcontract PI)
PI: Arpan Mohanty, MBBS
The Medical College of Virginia Foundation Bristol-Myers Sq Fdn


ESSENCE: The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis-NN9931-4553
11/05/2021 - 11/05/2026 (PI)
Novo Nordisk


TAK-999-3002: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency–Associated Liver Disease With METAVIR Stage F1 Fibrosis
08/30/2024 - 08/30/2026 (PI)
Takeda Pharmaceuticals


LINC: Leveraging Informatics for NAFLD Care
12/01/2019 - 12/31/2024 (PI)
Gilead Sciences


A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating …
05/16/2017 - 05/31/2024 (PI)
Intercept Pharmaceuticals, Inc.


Showing 10 of 13 results. Show All Results

Title

Spectroscopic interrogation of Upper Gastrointestinal Mucosa: A Less Intrusive Measure of Hepatic Venous Pressure Gradient
07/01/2018 - 06/01/2019 (PI)
American Association for the Study of Liver Diseases (AASLD)

Advanced/ Transplant Hepatology Training Award
07/01/2016 - 06/01/2017 (PI)
American Association for the Study of Liver Diseases (AASLD)


Yr Title Project-Sub Proj Pubs
2022 Unraveling Racial Disparities in Portal Hypertension: A Clinical, Spectroscopic andSNP Approach 5R21MD013631-03
2020 Unraveling Racial Disparities in Portal Hypertension: A Clinical, Spectroscopic and SNP Approach 7R21MD013631-02
2020 Unraveling Racial Disparities in Portal Hypertension: A Clinical, Spectroscopic and SNP Approach 1R21MD013631-01A1

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Ghusn W, Gala K, Mrad R, Salame M, Rahme SJ, Santiago HR, Mohanty A, Chiu L, Hashash JG, Chedid V. Disparities in the burden of gastrointestinal diseases: a comprehensive analysis of data from randomized clinical trials from 2000-2023. Ann Gastroenterol. 2025; 38(5):488-496. PMID: 40937058; PMCID: PMC12421361; DOI: 10.20524/aog.2025.0997;
     
  2. Mohanty A, Wang Y, Stoecker C. Screening for MASLD and Advanced Fibrosis Among Patients With Obesity: A Cost-Effectiveness Analysis. Obesity (Silver Spring). 2025 Oct; 33(10):1845-1848. PMID: 40879614
     
  3. Mohanty A, Austad K, Bosch NA, Long MT, Nolen-Doerr E, Walkey AJ, Drainoni ML, Rizo I, Fantasia KL. Assessing Clinician Engagement With a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic. Endocr Pract. 2025 Jul; 31(7):899-905.View Related Profiles. PMID: 40288606
     
  4. Wong YJ, Buckholz A, Sim A, Teng M, Wong R, Curry MP, De Roza MA, Baffy G, Teoh X, Chak E, Rustagi T, Chang J, Wong GW, Tandon P, Garcia-Tsao G, Abraldes JG, Mohanty A, Fortune B. Nonalcohol-related Cirrhosis Leads to Higher 6-week Mortality After Acute Variceal Bleeding Than Alcohol-related Cirrhosis. Clin Gastroenterol Hepatol. 2025 Sep; 23(10):1776-1785.e10.View Related Profiles. PMID: 39675401
     
  5. Kumar S, Mohanty A, Mantry P, Schwartz RE, Haff M, Therapondos G, Noureddin M, Dieterich D, Girgrah N, Cohn K, Savanth M, Fuchs M. Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems. BMC Prim Care. 2024 Jul 20; 25(1):265.View Related Profiles. PMID: 39033284; PMCID: PMC11265102; DOI: 10.1186/s12875-024-02517-y;
     
  6. Mohanty A, Garcia-Tsao G. Management of acute variceal bleeding. Clin Liver Dis (Hoboken). 2024; 23(1):e0176. PMID: 38952694; PMCID: PMC11216663; DOI: 10.1097/CLD.0000000000000176;
     
  7. Sun N, Prescott B, Ma J, Mohanty A, Long MT, Walker ME. Prevalence of Steatotic Liver Disease Subtypes and Association With Metabolic Risk Factors in the Framingham Heart Study. Clin Gastroenterol Hepatol. 2024 Nov; 22(11):2330-2333.View Related Profiles. PMID: 38857746
     
  8. Mohanty A, Cárdenas A. Securing the diagnosis of HRS-AKI: implications for current therapies. Expert Rev Gastroenterol Hepatol. 2023 Dec; 17(12):1233-1239. PMID: 37982156
     
  9. Fantasia KL, Austad K, Mohanty A, Long MT, Walkey A, Drainoni ML. Safety-Net Primary Care and Endocrinology Clinicians' Knowledge and Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A Mixed-Methods Evaluation. Endocr Pract. 2024 Mar; 30(3):270-277.View Related Profiles. PMID: 38184239
     
  10. Connolly JJ, Ahmed HS, Chung EC, Cabral HJ, Nagar A, Tami A, Schroy PC, Mohanty A. Estimate of Increase in Colorectal Cancer Diagnoses with Expansion of Fecal Immunochemical Testing in an Urban Safety-Net Population. Dig Dis Sci. 2024 Feb; 69(2):360-369.View Related Profiles. PMID: 38041763
     
Showing 10 of 34 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 34 publications over 15 distinct years, with a maximum of 6 publications in 2023 and 2024

YearPublications
20091
20122
20131
20141
20152
20162
20171
20182
20191
20202
20212
20222
20236
20246
20253


2018-2019 American Association for Study of Liver Diseases: Pilot Research Award
2016 American Association for the Study of Liver Diseases (AASLD): Hepatology Fellowship Award
2016-2017 American Association for Study of Liver Diseases: Advanced Transplant Hepatology Award
2015 American Association for the Study of Liver Diseases (AASLD): Fellows Travel Award
2015 Salix Pharmaceuticals: Fellowship2Leadership Fellows Program Travel Award
2015 Digestive Disease Week May 16-19, 2015, Washington DC: Liver Plenary Session Presentation
2012 University of Pittsburgh School of Medicine: Department of Medicine Research Day Award
2012-2015 European Association for the Study of Liver (EASL): Young Investigator Bursary
2008 Sri Devaraj Urs Medical College: Gold Medal Pharmacology
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Cirrhosis
Portal Hypertension
End Stage Liver Disease
Liver Cancer
Hepatocellular Carcinoma
Cancer Screening

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Diversity Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:

85 E. Concord St, 7th Floor
Boston MA 02118
Google Map

617.638.3019
Download vCard

Mohanty's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (112) concept(s)
_
Co-Authors
See all (23) people
_
Similar People
See all (60) people
_
Same Department
Search Department